Pasithea Therapeutics Corp. — Form D
Pasithea Therapeutics Corp. of MIAMI BEACH, FL, a company, filed a Form D exempt-offering notice with the SEC on 2021-12-07. The offering totals $30.4M, of which $30.4M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2021-12-07
- Form: D
- Accession: 0001213900-21-063810
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $30.4M
- Amount sold: $30.4M
- Investors: 21
- Date of first sale: 2021-11-29
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-423899
Issuer
- Name: Pasithea Therapeutics Corp.
- CIK: 0001841330
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2020
- Address: 1111 LINCOLN ROAD, MIAMI BEACH, FL, 33139
- Phone: (702) 514-4174
Officers, directors & promoters (14)
| Name | Role | Location |
|---|
| Yassine Bendiabdallah | Director | Miami Beach, FL |
| Simon Dumesnil | Director | Miami Beach, FL |
| Emer Dos Reis Leahy | Director | Miami Beach, FL |
| Tiago Andre Dos Reis Marques | Director | Miami Beach, FL |
| Lawrence Steinman | Director | San Carlos, CA |
| Yassine Bendiabdallah | Executive Officer | Miami Beach, FL |
| Stanley M Gloss | Executive Officer | Miami Beach, FL |
| Tiago Andre Dos Reis Marques | Executive Officer | Miami Beach, FL |
| Lawrence Reis Steinman | Director | Miami Beach, FL |
| Tiago Reis Marques | Director | Miami Beach, FL |
| Israel Maxx Abramowitz | Director | Miami Beach, FL |
| Israel Maxx Abramowitz | Executive Officer | Miami Beach, FL |
| Craig Maxx Auringer | Director | Miami Beach, FL |
| Craig Maxx Auringer | Executive Officer | Miami Beach, FL |
Other filings by this issuer (2)
More